CO2018001628A2 - Composiciones y formulaciones antimicrobianas - Google Patents

Composiciones y formulaciones antimicrobianas

Info

Publication number
CO2018001628A2
CO2018001628A2 CONC2018/0001628A CO2018001628A CO2018001628A2 CO 2018001628 A2 CO2018001628 A2 CO 2018001628A2 CO 2018001628 A CO2018001628 A CO 2018001628A CO 2018001628 A2 CO2018001628 A2 CO 2018001628A2
Authority
CO
Colombia
Prior art keywords
compositions
phase
antimicrobial formulations
enzyme
substrate
Prior art date
Application number
CONC2018/0001628A
Other languages
English (en)
Inventor
Sophie Constance Cox
Thomas Jon Hall
Liam Michael Grover
Rami Salib
Thomas Patton
James Brennan
John Reginald Barrett
Ian Staples
Original Assignee
Matoke Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1513045.3A external-priority patent/GB201513045D0/en
Application filed by Matoke Holdings Ltd filed Critical Matoke Holdings Ltd
Publication of CO2018001628A2 publication Critical patent/CO2018001628A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/443Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004Glucose oxidase (1.1.3.4)

Abstract

Se describen composiciones para generar actividad antimicrobiana. Las composiciones comprende: una primera fase; una segunda fase; una enzima que es capaz de convertirse a un sustrato para liberar peróxido de hidrógeno; y una sustancia que incluye un sustrato para la enzima, en donde la primera fase y la segunda fase no son miscibles. Las composiciones pueden formularse como coloides, suspensiones o emulsiones, especialmente como cremas o rocíos. Se describen métodos para hacer las composiciones, así como su uso para el tratamiento de infecciones microbianas.
CONC2018/0001628A 2015-07-23 2018-02-20 Composiciones y formulaciones antimicrobianas CO2018001628A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1513045.3A GB201513045D0 (en) 2015-07-23 2015-07-23 Antimicrobial compositions and formulations
GB201606249 2016-04-12
PCT/GB2016/052258 WO2017013448A1 (en) 2015-07-23 2016-07-22 Antimicrobial compositions and formulations releasing hydrogen peroxide

Publications (1)

Publication Number Publication Date
CO2018001628A2 true CO2018001628A2 (es) 2018-11-22

Family

ID=56555490

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2018/0001628A CO2018001628A2 (es) 2015-07-23 2018-02-20 Composiciones y formulaciones antimicrobianas

Country Status (16)

Country Link
US (1) US20180318399A1 (es)
EP (1) EP3324998A1 (es)
JP (1) JP2018527320A (es)
KR (1) KR20180051501A (es)
CN (1) CN107847566A (es)
AU (1) AU2016296150A1 (es)
BR (1) BR112018001279A2 (es)
CA (1) CA2990326A1 (es)
CO (1) CO2018001628A2 (es)
GB (1) GB2556567A (es)
HK (1) HK1256251A1 (es)
MA (1) MA42910A (es)
MX (1) MX2018001002A (es)
PH (1) PH12018500374A1 (es)
RU (1) RU2018105622A (es)
WO (1) WO2017013448A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3245871A1 (en) 2014-04-30 2017-11-22 Matoke Holdings Limited Antimicrobial compositions
WO2018065789A1 (en) * 2016-10-06 2018-04-12 Matoke Holdings Limited Antimicrobial compositions
WO2018091890A1 (en) * 2016-11-15 2018-05-24 Matoke Holdings Limited Antimicrobial compositions and formulations
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
WO2019077336A1 (en) * 2017-10-16 2019-04-25 Matoke Holdings Limited DOUBLE DISTRIBUTOR CONTAINING WATER AND ANTIMICROBIAL COMPOSITION
CN107668320A (zh) * 2017-11-03 2018-02-09 杭州市农业科学研究院 以蜂蜜为原料的饲料添加剂及其制备方法
WO2020022989A2 (en) * 2018-05-02 2020-01-30 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Topical compositions for baby skin care
CN110734563B (zh) * 2018-07-20 2022-05-17 南京理工大学 细菌纤维素/鸸鹋油复合膜及其制备方法
EP3946481A2 (en) 2019-03-27 2022-02-09 Matoke Holdings Limited Antimicrobial compositions
CN111631271A (zh) * 2020-05-22 2020-09-08 南昌大学 一种稳定w/o/w型多重乳液的制备方法
WO2023227599A1 (en) * 2022-05-23 2023-11-30 Atlantic Technological University Antimicrobial coating composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9002422D0 (en) * 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
US5980875A (en) * 1996-04-12 1999-11-09 Mousa; Mahmoud A. Honey preparations
US5972355A (en) * 1997-09-30 1999-10-26 E-L Management Corp. Stable compositions containing biologically active components
FR2769504B1 (fr) * 1997-10-13 2000-03-10 Oreal Utilisation du miel en tant qu'agent diminuant l'adhesion des micro-organismes
NL1017333C2 (nl) * 2001-02-12 2002-08-13 Gent Natural Products Van Cosmetisch resp. farmaceutisch preparaat.
AU2003234758B2 (en) * 2002-08-13 2009-04-02 Derma Sciences, Inc. Composition
BE1017155A3 (nl) * 2006-06-01 2008-03-04 Sanomedical Bvba Wondverzorgingsproduct.
GB0619786D0 (en) * 2006-10-06 2006-11-15 Inst Of Technology Sligo An antimicrobial and immunostimulatory system
DE102008034944B4 (de) * 2008-07-26 2017-03-16 Arivine Pharma Ag Mikroemulsion
JP5750404B2 (ja) * 2012-06-14 2015-07-22 株式会社山田蜂蜜研究所 抗菌剤及び化粧料

Also Published As

Publication number Publication date
PH12018500374A1 (en) 2018-08-20
US20180318399A1 (en) 2018-11-08
CA2990326A1 (en) 2017-01-26
RU2018105622A3 (es) 2020-02-21
BR112018001279A2 (pt) 2018-09-11
HK1256251A1 (zh) 2019-09-20
MA42910A (fr) 2018-05-30
WO2017013448A1 (en) 2017-01-26
GB201801667D0 (en) 2018-03-21
CN107847566A (zh) 2018-03-27
JP2018527320A (ja) 2018-09-20
EP3324998A1 (en) 2018-05-30
MX2018001002A (es) 2018-09-28
RU2018105622A (ru) 2019-08-27
KR20180051501A (ko) 2018-05-16
AU2016296150A1 (en) 2018-03-01
GB2556567A (en) 2018-05-30

Similar Documents

Publication Publication Date Title
CO2018001628A2 (es) Composiciones y formulaciones antimicrobianas
UY37563A (es) Aislados de bacillus y usos de los mismos
CL2017001923A1 (es) Derivados de 9h-pirrolo-dipiridina
UY34605A (es) Derivados de arilalquiloxipirimidina e insecticidas agrohortícolas que comprenden dichos derivados como principios activos, y método de uso de los mismos
CO2019006673A2 (es) Polimorfos
BR112017027147A2 (pt) agente estimulante de restauração/crescimento de cabelo
CL2021000415A1 (es) Vesículas derivadas de lactobacillus paracasei y uso de las mismas
EA201692334A1 (ru) Кортикостероидные композиции для местного применения
CL2017002856A1 (es) Compuestos de tioéter como inhibidores de la nitrificación
CL2019001737A1 (es) Polimorfos.
CR20160433A (es) Nuevos compuestos
CR20160044S (es) Dispensador de jabon
NI201700078A (es) Pirazolpiridinaminas
MX2020003495A (es) Derivados de acido boronico y sintesis de los mismos.
DOP2016000007A (es) Pirazolpiridinas sustituidas
MX2016013894A (es) Composicion para el cuidado del cuero cabelludo.
DOP2016000268A (es) Compuestos de azol amido–sustituidos como inhibidores de tnks1 y/o tnks2
CO2019011547A2 (es) Compuesto sólido cristalino novedoso de clorhidrato de 3-fenil-4-propil-1-(piridin-2-il)-1h-pirazol-5-ol
CL2019002574A1 (es) Moduladores de la expresión de pcsk9.
EA202090732A1 (ru) Составы для трансдермального введения
CO2022002898A2 (es) Composiciones que comprenden tigolaner para el control de parásitos
NI202000042A (es) Polimorfos
MX2018002859A (es) Extracto de gardenia para colorear la piel.
CL2018002368A1 (es) Formulaciones de oritavancina
AR109407A1 (es) Compuesto de 1-acetil-3-fenilurea y su uso